Inventor · disambiguated record
Rocco Mazzaferro
Also filed as: MAZZAFERRO ROCCO
18 granted patents·65 citations·filing 2004–2023
93Inventor score
Files withCENTREXION THERAPEUTICS CORP8BOEHRINGER INGELHEIM INT3EBEL HEINER3ITALFARMACO SPA2CT XION THERAPEUTICS CORP1
Top patents by PatentIndex Score
18 records- 0191US11046706B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 29, 2021·3 cites·26 claims
- 0291US10196402B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Feb 5, 2019·7 cites·31 claims
- 0389US11731981B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 22, 2023·1 cites·20 claims
- 0489US9670222B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2014·Granted Jun 6, 2017·9 cites·23 claims
- 0588US8765949B2CCR2 receptor antagonists and uses thereofEBEL HEINER·Filed 2010·Granted Jul 1, 2014·9 cites·39 claims
- 0686US12209094B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jan 28, 2025·0 cites·20 claims
- 0786US9789082B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2016·Granted Oct 17, 2017·5 cites·38 claims
- 0885US10675268B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 9, 2020·2 cites·15 claims
- 0985US10166214B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Jan 1, 2019·4 cites·25 claims
- 1083US9371282B2Somatostatin receptor subtype 4 (SSTR4) agonistsCT XION THERAPEUTICS CORP·Filed 2014·Granted Jun 21, 2016·8 cites·48 claims
- 1179US7635788B2Alpha-amino acid derivatives with antiinflammatory activityITALFARMACO SPA·Filed 2005·Granted Dec 22, 2009·4 cites·9 claims
- 1278US10071974B2Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonistsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Sep 11, 2018·2 cites·25 claims
- 1376US10183940B2Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonistsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 22, 2019·2 cites·15 claims
- 1475US10577336B2Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonistsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Mar 3, 2020·1 cites·12 claims
- 1572US9012489B2Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicamentGIOVANNINI RICCARDO·Filed 2012·Granted Apr 21, 2015·2 cites·47 claims
- 1672US8877745B2CCR2 receptor antagonists, method for producing the same, and use thereof as medicamentsEBEL HEINER·Filed 2011·Granted Nov 4, 2014·2 cites·11 claims
- 1767US7235689B2Hydroxamic acid derivatives having anti-inflammatory actionITALFARMACO SPA·Filed 2004·Granted Jun 26, 2007·4 cites·14 claims
- 1839US8946218B2CCR2 receptor antagonists, method for producing the same, and use thereof as medicamentsEBEL HEINER·Filed 2011·Granted Feb 3, 2015·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Rocco Mazzaferro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →